Kolon TissueGene, Inc. (KOSDAQ: 950160)

Market Cap	2.29T
Revenue	n/a
Net Income	n/a
Shares Out	79.56M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	230,020
Average Volume	474,369
Open	28,500
Previous Close	28,500
Day's Range	27,500 - 29,000
52-Week Range	8,610 - 31,450
Beta	-0.59
RSI	59.13
Earnings Date	n/a

About Kolon TissueGene

Kolon TissueGene, Inc. develops cell therapies to target various orthopedic diseases and degenerative disorders. The company is developing cell therapies for osteoarthritis and musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 29
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950160